Clinical Trials/ACTRN12617000973314

ACTRN12617000973314

Recruiting

未知

Efficacy of a two bag N-acetylcysteine(NAC) regimen to treat paracetamol overdose (2NAC study)

Monash Health0 sites3,000 target enrollmentJuly 6, 2017

Conditionsparacetamol overdose Mental Health - Suicide Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Overview

Phase: 未知
Intervention: Not specified
Conditions: paracetamol overdose
Sponsor: Monash Health
Enrollment: 3000
Status: Recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

July 6, 2017

End Date

TBD

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Eligibility Criteria

Inclusion Criteria

•All paracetamol overdose treated with acetylcysteine

Exclusion Criteria

•No treatment with acetylcysteine or overdose of paracetamol.

Outcomes

Primary Outcomes

Not specified

Similar Trials

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine DependenceMethamphetamine Dependence

NCT00332605University of Chicago45

acetylcysteine in the treatment of diarrhea caused by rotavirusDiarrhea caused by rotavirus.Rotaviral enteritisA08.0

IRCT20181208041882N13Yazd University of Medical Sciences64

Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)

IRCT20090808002306N7Esfahan University of Medical Sciences45

Not yet recruiting

AC-PTLD TrialTuberculosis

PACTR202407655325739The Aurum Institute484

Evaluation of The Effect of N-acetylcysteine in The Prevention of Vancomycin-Induced Renal Disorder.

IRCT20150721023282N6Esfahan University of Medical Sciences60